GACL Reports Record Q1 FY27 Revenue of ₹1,225 Cr, EBITDA Up 83%
GACL reported its highest-ever quarterly revenue of ₹1,224.84 Crores for Q1 FY27, a 14% increase year-on-year. EBITDA rose 83% to ₹229 Crores, and Profit Before Tax increased 1000% to ₹110 Crores. The company also received in-principle approval for a new HCL synthesis Unit at Dahej, costing approximately ₹55 Crores.
The announcement includes record financial results and approval for a new capital expenditure project which is expected to enhance production and utilization, indicating a significant positive impact on the company's future performance and operations.
The company reported record-breaking revenue, significant growth in EBITDA and Profit Before Tax, and received board approval for a new capex project, all indicating positive financial and operational performance.
Gujarat Alkalies and Chemicals Limited (GACL) has announced its unaudited financial results for the first quarter ended June 30, 2026. The company achieved its highest-ever quarterly revenue, reporting ₹1,224.84 Crores, a 14% increase from ₹1,073.45 Crores in the corresponding quarter of the previous year. This growth was driven by product mix optimization and expansion into new export markets.
EBITDA for the quarter surged by 83% to ₹229 Crores, up from ₹125 Crores in Q1 FY26. Profit Before Tax saw a significant increase of 1000%, reaching ₹110 Crores compared to ₹10 Crores in the prior year's quarter. The company attributed these strong operating performances to higher integration of renewable energy.
GACL reported that the share of renewable energy in its power consumption increased to 59% from 39% in the previous year's quarter, aligning with its strategy to expand renewable power usage and contribute to India's net-zero carbon commitments. The company also continues to focus on efficiency through Project Ahvaan, which aims to enhance operational efficiencies, reduce costs, optimize plant capacity utilization, and leverage digitization and AI.
Furthermore, the Board of Directors granted in-principle approval for a new HCL synthesis Unit at Dahej, with an estimated project cost of ₹55 Crores. This unit is expected to improve chlorine utilization and optimize Caustic Soda production, with the generated HCL to be utilized in the upcoming Phosphoric Acid plant at Dahej. The Board also approved the Vision 2047 document.
What to do with a filing like this
Gujarat Alkalies and Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Alkalies and Chemicals Limited. Read the original for the full detail.